Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
INNOVACAP.NS
BuyPremium GrowerInnova Captab Limited · Healthcare · India · $707M · Avg Vol: $1M/d
79
StockRankGet insider-trade alerts
Q
66
V
22
M
87
P/E (TTM)
44.1x
ROE
12.9%
D/E
0.3x
Dividend %
0.2%
COMPANY DESCRIPTION
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.3B | 10.8B | 12.3B | 16.0B | 20.1% | 17.5B | 20.3B | 24.4B | 23.4% |
| EPS (INR) | 11.87 | 18.66 | 22.41 | 24.63 | 27.5% | 26.95 | 33.60 | 45.35 | 35.7% |
| Shares | 57.2M | 57.2M | 57.2M | 57.2M | 0.0% | 57.2M | — | — | — |
| Debt | 2.4B | 2.5B | 3.4B | 3.4B | 13.2% | 3.4B | — | — | — |
| Equity | 2.8B | 8.3B | 9.6B | 10.9B | 58.0% | — | — | — | — |
| Op CF | 671.2M | 1.5B | 638.4M | 1.2B | 20.2% | 1.2B | — | — | — |
| Inv CF | -908.4M | -5.0B | -1.5B | -1.1B | — | — | — | — | — |
| Fin CF | 270.9M | 3.6B | 915.3M | -217.2M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+22.6%
SMA 50SMA 200
Close
$12.50
RSI (14)
68.6
52W High
$12.62
From 52W High
1.0%
SCORE BREAKDOWN
Quality
66
ROIC
16.6%86.3
ROE
12.9%78.1
GP/Assets
32.7%67.9
Op. Margin
13.0%70.2
FCF/Assets
2.6%58.4
Piotroski
668.8
Int. Cover
12.1x64.8
D/E Ratio
0.32x40.1
Current Ratio
1.87x35.9
Value
22
P/E (TTM)
44.1x25.4
EV/EBITDA
27.2x23.5
P/FCF
139.7x11.8
P/B
6.2x21.6
P/S
3.9x49.3
Div Yield
0.2%3.8
Momentum
87
52W High %
99%99.1
RS 6M
73%94.3
SMA 50/200
1.24x90.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+68%64.3
Q Growth
42%71.1
FUNDAMENTALS
Market Cap
$707M
P/E (Forward)
26.2x
Gross Margin
34.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of INNOVACAP.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| INNOVACAP.NS | Innova Captab Limited(you) | $707M | 79 | Buy |
| FDC.NS | FDC Limited | $594M | 76 | Buy |
| MOREPENLAB.NS | Morepen Laboratories Limited | $677M | 85 | Strong Buy |
| RPGLIFE.NS | RPG Life Sciences Limited | $489M | 79 | Buy |
| SPARC.NS | Sun Pharma Advanced Research Company Limited | $696M | 89 | Strong Buy |
| BLISSGVS.NS | Bliss GVS Pharma Limited | $810M | 87 | Strong Buy |
| IOLCP.NS | IOL Chemicals and Pharmaceuticals Limited | $653M | 89 | Strong Buy |
| AARTIDRUGS.NS | Aarti Drugs Limited | $406M | 80 | Strong Buy |
| SOLARA.NS | Solara Active Pharma Sciences Limited | $357M | 81 | Strong Buy |
| INDSWFTLAB.NS | Ind-Swift Laboratories Limited | $356M | 81 | Strong Buy |
Peer medians: ROE 11.8% · P/E 42.5x · Gross margin 59.4%